Showing results (51-60 of 308) with videos related to
Sort By:
Pageof 31
Arthritis and Rheumatism|August 1, 1981
Variability of plasma hydralazine concentrations in male hypertensive patientsT M Ludden, J L McNay, A M Shepherd, et al.Archives of Neurology|February 1, 1979
Rapid metabolism of phenytoin: a method of calculating proper dosageD W Hawkins, T M Ludden, S F Hoffman, et al.Clinical Pharmacology and Therapeutics|December 1, 1980
Hydralazine kinetics after single and repeated oral dosesA M Shepherd, T M Ludden, J L McNay, et al.Investigational New Drugs|January 1, 1983
Pharmacokinetics of high dose melphalanM R Hersh, T M Ludden, J G Kuhn, et al.Therapeutic Drug Monitoring|January 1, 1986
Measurement of lidocaine free concentrationC L Beach, T M Ludden, W A Clementi, et al.Therapeutic Drug Monitoring|January 1, 1983
Predicting phenytoin dosages using Bayesian feedback: a comparison with other methodsG J Yuen, J W Taylor, T M Ludden, et al.Clinical Pharmacology and Therapeutics|December 1, 1980
Hydralazine kinetics in hypertensive patients after intravenous administrationT M Ludden, A M Shepherd, J L McNay, et al.Clinical Pharmacology and Therapeutics|February 1, 1980
Displacement of phenytoin from plasma binding sites by salicylateD G Fraser, T M Ludden, R P Evens, et al.American Journal of Hospital Pharmacy|February 1, 1980
Phenytoin toxicity and blood levels after a large oral doseR P Evens, D G Fraser, T M Ludden, et al.Clinical Pharmacology and Therapeutics|August 1, 1983
Effect of intravenous dose on hydralazine kinetics after administrationT M Ludden, A M Shepherd, J L McNay, et al.Pageof 31